EXAI
Exscientia Plc American Depositary SharesEXAI
EXAI
Delisted
EXAI was delisted on the 19th of November, 2024.
About: Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe, and efficacious compounds for clinical testing in humans. The company is focused on the discovery and development of small-molecule drug candidates.
Employees: 483
Financial journalist opinion
Neutral
Business Wire
2 months ago
HAYA Therapeutics Appoints Former Exscientia Executive Dr. Richard Law as Chief Business Officer
LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)-- #Exscientia--HAYA Therapeutics appoints former Exscientia executive Dr. Richard Law as Chief Business Officer.
Neutral
Business Wire
7 months ago
Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced the advancement of two additional discovery programmes within its collaboration with Sanofi, with Exscientia receiving an aggregate of $15 million in milestone payments. Both lead compounds have met the product profile requirements, set by both Exscientia and Sanofi, to enable a transition to the lead optimisation phase within the collaboration. Both programmes have also shown a high level of differentiation in earl.
Neutral
Accesswire
7 months ago
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of RXRX and EXAI
NEW YORK, NY / ACCESSWIRE / October 11, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) , relating to its proposed merger with Exscientia PLC.
Neutral
Business Wire
7 months ago
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced three abstracts to be presented at the 36th EORTC-NCI-AACR (ENA) Symposium 2024 from October 23-25, in Barcelona, Spain. “As our precision-designed LSD1 and MALT1 inhibitors continue to progress towards the clinic, we are excited to share new preclinical data from both programmes,” said David Hallett, Ph.D., interim Chief Executive Officer and Chief Scientific Officer of Exscientia. “These posters, as well as an add.
Neutral
Business Wire
8 months ago
Brilliant NextGen Will Expand Solutions for Builders Through its Acquisition by Private Investors
SAN MATEO, Calif.--(BUSINESS WIRE)--Brilliant, the designer and manufacturer of innovative smart home controls and home automation systems shares its acquisition by Almeida Strategic Investments, led by brothers Evan and Michael Almeida, in partnership with David Blum, owner of Cullinan Holdings. The private investment fuels the next generation of innovation for Brilliant's award-winning smart home controls, switches, and plugs trusted in thousands of homes in North America. The new organizatio.
Neutral
Business Wire
8 months ago
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Methode Electronics, Inc. (MEI) Investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Methode Electronics, Inc. (MEI) Investors.
Neutral
Business Wire
8 months ago
BreachBits and SecurityStudio Collaborate to Enhance Virtual CISO Credentials and Automated Capabilities
ANNAPOLIS, Md.--(BUSINESS WIRE)--BreachBits is pleased to announce its collaboration with SecurityStudio for 2024. SecurityStudio is a cyber risk management platform that focuses on holistic information security for your organization, team, and vendors. BreachBits delivers security and compliance capabilities via the BreachRisk platform. BreachRisk leverages AI and automation to provide scalable cyber risk monitoring and testing from an attacker's perspective. These solutions empower organizati.
Neutral
Business Wire
8 months ago
AM Best Comments on Credit Ratings of American National Group's Members Following Announced Coinsurance Agreement With Reinsurance Group of America, Incorporated
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has commented that the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of “a+” (Excellent) of American National Insurance Company (ANICO) and its affiliates, American National Life Insurance Company of Texas and American National Life Insurance Company of New York (Glenmont, NY), collectively known as American National Group (ANG), remain unchanged following an announced coinsurance arrangement whereby ANG will cede $3.5.
Neutral
Business Wire
8 months ago
Suffolk Texas Named Best Place to Work for Two Consecutive Years
DALLAS--(BUSINESS WIRE)--Suffolk, one of the largest and most innovative real estate and construction enterprises in the country, is proud to announce that the Dallas Business Journal has named its Dallas office as one of its Best Places to Work for the second year in a row. The annual list recognizes North Texas companies that have gone above and beyond to create an exemplary workplace, and Suffolk's consecutive wins highlight the growing impact the local team has on the region. Suffolk's Dall.
Neutral
Business Wire
8 months ago
Exscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced that David Hallett, interim Chief Executive Officer and Chief Scientific Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024 at 7:00 a.m. EDT (12:00 p.m. BST). A live webcast of the fireside chat will be available on the Company's website, under the “Investors & Media” section at investors.exscientia.ai. An archived replay of.
Charts implemented using Lightweight Charts™